| Hospice Del Sol 3634 N Rancho, Las Vegas, NV, 89130 | |
| (702) 528-4782 |
News Archive
It is still unclear what the impact is on humans, animals and plants of synthetic nanomaterials released into the environment or used in products. It's very difficult to detect these nanomaterials in the environment since the concentrations are so low and the particles so small. Now the partners in the NanoUmwelt project have developed a method that is capable of identifying even minute amounts of nanomaterials in environmental samples.
ProPhase Labs, makers of Cold-EEZE, a leader in over-the-counter (OTC) homeopathic cold remedies, continues to pioneer the category as they launch their first-ever Cold-EEZE Oral Spray. The new Oral Spray is formulated with zinc gluconate, the same effective active ingredient found in the best-selling, clinically proven and #1 pharmacist recommended Cold-EEZE lozenges.
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
A new study from the Journal of Marriage and Family shows that contrary to popular anxieties about slacker young adults who refuse to grow up, or indulgent parents who stifle their adult children's development by continuing to support them, there is evidence that parental assistance in early adulthood promotes progress toward autonomy and self-reliance.
LeapFrog Investments, the world's first microinsurance fund, announced today that it has surged past its $100 million target capitalization, months ahead of schedule. The fund invests in high-growth, high-impact insurance and financial services companies in countries including India, the Philippines, South Africa, Kenya, and Ghana.
› Verified 3 days ago
| Name | Hospice Del Sol |
|---|---|
| Location | 3634 N Rancho, Las Vegas, Nevada |
| Hospice ID | 291524 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 010 |
News Archive
It is still unclear what the impact is on humans, animals and plants of synthetic nanomaterials released into the environment or used in products. It's very difficult to detect these nanomaterials in the environment since the concentrations are so low and the particles so small. Now the partners in the NanoUmwelt project have developed a method that is capable of identifying even minute amounts of nanomaterials in environmental samples.
ProPhase Labs, makers of Cold-EEZE, a leader in over-the-counter (OTC) homeopathic cold remedies, continues to pioneer the category as they launch their first-ever Cold-EEZE Oral Spray. The new Oral Spray is formulated with zinc gluconate, the same effective active ingredient found in the best-selling, clinically proven and #1 pharmacist recommended Cold-EEZE lozenges.
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
A new study from the Journal of Marriage and Family shows that contrary to popular anxieties about slacker young adults who refuse to grow up, or indulgent parents who stifle their adult children's development by continuing to support them, there is evidence that parental assistance in early adulthood promotes progress toward autonomy and self-reliance.
LeapFrog Investments, the world's first microinsurance fund, announced today that it has surged past its $100 million target capitalization, months ahead of schedule. The fund invests in high-growth, high-impact insurance and financial services companies in countries including India, the Philippines, South Africa, Kenya, and Ghana.
› Verified 3 days ago
| NPI Number | 1568643799 |
| Organization Name | Hospice Del Sol Llc |
| Address | 3634 N Rancho Dr Las Vegas, Nevada, 89130 |
| Phone Number | (702)528-4782 |
News Archive
It is still unclear what the impact is on humans, animals and plants of synthetic nanomaterials released into the environment or used in products. It's very difficult to detect these nanomaterials in the environment since the concentrations are so low and the particles so small. Now the partners in the NanoUmwelt project have developed a method that is capable of identifying even minute amounts of nanomaterials in environmental samples.
ProPhase Labs, makers of Cold-EEZE, a leader in over-the-counter (OTC) homeopathic cold remedies, continues to pioneer the category as they launch their first-ever Cold-EEZE Oral Spray. The new Oral Spray is formulated with zinc gluconate, the same effective active ingredient found in the best-selling, clinically proven and #1 pharmacist recommended Cold-EEZE lozenges.
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
A new study from the Journal of Marriage and Family shows that contrary to popular anxieties about slacker young adults who refuse to grow up, or indulgent parents who stifle their adult children's development by continuing to support them, there is evidence that parental assistance in early adulthood promotes progress toward autonomy and self-reliance.
LeapFrog Investments, the world's first microinsurance fund, announced today that it has surged past its $100 million target capitalization, months ahead of schedule. The fund invests in high-growth, high-impact insurance and financial services companies in countries including India, the Philippines, South Africa, Kenya, and Ghana.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 95.1 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 77.7 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 86.4 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 89.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 89.3 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.5 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
It is still unclear what the impact is on humans, animals and plants of synthetic nanomaterials released into the environment or used in products. It's very difficult to detect these nanomaterials in the environment since the concentrations are so low and the particles so small. Now the partners in the NanoUmwelt project have developed a method that is capable of identifying even minute amounts of nanomaterials in environmental samples.
ProPhase Labs, makers of Cold-EEZE, a leader in over-the-counter (OTC) homeopathic cold remedies, continues to pioneer the category as they launch their first-ever Cold-EEZE Oral Spray. The new Oral Spray is formulated with zinc gluconate, the same effective active ingredient found in the best-selling, clinically proven and #1 pharmacist recommended Cold-EEZE lozenges.
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
A new study from the Journal of Marriage and Family shows that contrary to popular anxieties about slacker young adults who refuse to grow up, or indulgent parents who stifle their adult children's development by continuing to support them, there is evidence that parental assistance in early adulthood promotes progress toward autonomy and self-reliance.
LeapFrog Investments, the world's first microinsurance fund, announced today that it has surged past its $100 million target capitalization, months ahead of schedule. The fund invests in high-growth, high-impact insurance and financial services companies in countries including India, the Philippines, South Africa, Kenya, and Ghana.
› Verified 3 days ago
| Home Health Aides | 0.05 |
| Counselors | 0.05 |
| Medical Social Workers | 0.05 |
| Physicians | 0.5 |
| Registered Nurses | 1.1 |
| Total Employees | 1.75 |
|---|
News Archive
It is still unclear what the impact is on humans, animals and plants of synthetic nanomaterials released into the environment or used in products. It's very difficult to detect these nanomaterials in the environment since the concentrations are so low and the particles so small. Now the partners in the NanoUmwelt project have developed a method that is capable of identifying even minute amounts of nanomaterials in environmental samples.
ProPhase Labs, makers of Cold-EEZE, a leader in over-the-counter (OTC) homeopathic cold remedies, continues to pioneer the category as they launch their first-ever Cold-EEZE Oral Spray. The new Oral Spray is formulated with zinc gluconate, the same effective active ingredient found in the best-selling, clinically proven and #1 pharmacist recommended Cold-EEZE lozenges.
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
A new study from the Journal of Marriage and Family shows that contrary to popular anxieties about slacker young adults who refuse to grow up, or indulgent parents who stifle their adult children's development by continuing to support them, there is evidence that parental assistance in early adulthood promotes progress toward autonomy and self-reliance.
LeapFrog Investments, the world's first microinsurance fund, announced today that it has surged past its $100 million target capitalization, months ahead of schedule. The fund invests in high-growth, high-impact insurance and financial services companies in countries including India, the Philippines, South Africa, Kenya, and Ghana.
› Verified 3 days ago
| Others | 0.02 |
| Total Volunteers | 0.02 |
|---|
News Archive
It is still unclear what the impact is on humans, animals and plants of synthetic nanomaterials released into the environment or used in products. It's very difficult to detect these nanomaterials in the environment since the concentrations are so low and the particles so small. Now the partners in the NanoUmwelt project have developed a method that is capable of identifying even minute amounts of nanomaterials in environmental samples.
ProPhase Labs, makers of Cold-EEZE, a leader in over-the-counter (OTC) homeopathic cold remedies, continues to pioneer the category as they launch their first-ever Cold-EEZE Oral Spray. The new Oral Spray is formulated with zinc gluconate, the same effective active ingredient found in the best-selling, clinically proven and #1 pharmacist recommended Cold-EEZE lozenges.
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
A new study from the Journal of Marriage and Family shows that contrary to popular anxieties about slacker young adults who refuse to grow up, or indulgent parents who stifle their adult children's development by continuing to support them, there is evidence that parental assistance in early adulthood promotes progress toward autonomy and self-reliance.
LeapFrog Investments, the world's first microinsurance fund, announced today that it has surged past its $100 million target capitalization, months ahead of schedule. The fund invests in high-growth, high-impact insurance and financial services companies in countries including India, the Philippines, South Africa, Kenya, and Ghana.
› Verified 3 days ago
| Nathan Adelson Hospice Location: 4141 S Swenson Street, Las Vegas, Nevada, 89119 Phone: (702) 528-4782 |
| Southwest Medical Associates Hospice And Palliativ Location: 1701 W Charleston Ste 150, Las Vegas, Nevada, 89102 Phone: (702) 528-4782 |
| Creekside Hospice Location: 3530 E Flamingo Road Suite 285, Las Vegas, Nevada, 89121 Phone: (702) 528-4782 |
| Always Better Care Hospice Location: 6950 W Via Olivero Ste B4, Las Vegas, Nevada, 89117 Phone: (702) 528-4782 |